EIF4A

Clinical trials for EIF4A explained in plain language.

Never miss a new study

Get alerted when new EIF4A trials appear

Sign up with your email to follow new studies for EIF4A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a new drug combo outsmart resistant breast cancer?

Disease control Not yet recruiting

This phase 1 trial is testing whether combining the experimental drug zotatifin with the chemotherapy carboplatin can help people with advanced triple-negative breast cancer (TNBC) that has not responded to standard treatments. The study aims to find the safest and most effective…

Matched conditions: EIF4A

Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Sep 09, 2026 16:00 UTC

EIF4A

Get alerted when new EIF4A trials appear

Can a new drug combo outsmart resistant breast cancer?